“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...

If you've been using Zyrtec or Xyzal to combat your allergy symptoms this year, an FDA warning wants you to be aware of this ...

Rilzabrutinib is a promising treatment option for patients with chronic spontaneous urticaria who are refractory to antihistamines.

Panelists discuss how ruxolitinib provides comprehensive benefits for polycythemia vera patients beyond count control, highlighting its remarkable ability to rapidly alleviate severe pruritus (often ...

The FDA has identified over 200 global cases of severe itching, or pruritus, occurring in patients who stopped long-term use ...

The U.S. Food and Drug Administration has issued a warning that people who have used certain common allergy medications may ...

The US FDA issued a warning on Saturday that some popular allergy medications could cause a rare but severe itching side ...

Spring allergy season is in full swing, but the FDA has issued a warning about a rare but serious “severe itching” side effect from popular allergy medications that has affected ...

The U.S. Food and Drug Administration has issued a warning about a rare but severe reaction that can happen to people who ...

Some patients may suffer from unbearable itching across their entire body after stopping common allergy medications, health ...

Although the side effect is rare, the FDA said some patients experienced severe itching that required medical attention.